rs28361212

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003672.4(CDC14A):​c.309A>C​(p.Ala103Ala) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0169 in 1,597,026 control chromosomes in the GnomAD database, including 4,021 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.091 ( 2173 hom., cov: 32)
Exomes 𝑓: 0.0091 ( 1848 hom. )

Consequence

CDC14A
NM_003672.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00002205
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -4.80

Publications

5 publications found
Variant links:
Genes affected
CDC14A (HGNC:1718): (cell division cycle 14A) The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
CDC14A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic deafness 105
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive nonsyndromic hearing loss 32
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, PanelApp Australia
  • hearing impairment and infertile male syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 1-100390824-A-C is Benign according to our data. Variant chr1-100390824-A-C is described in ClinVar as Benign. ClinVar VariationId is 506035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.8 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC14ANM_003672.4 linkc.309A>C p.Ala103Ala splice_region_variant, synonymous_variant Exon 4 of 16 ENST00000336454.5 NP_003663.2 Q9UNH5-1Q59EF4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC14AENST00000336454.5 linkc.309A>C p.Ala103Ala splice_region_variant, synonymous_variant Exon 4 of 16 1 NM_003672.4 ENSP00000336739.3 Q9UNH5-1

Frequencies

GnomAD3 genomes
AF:
0.0905
AC:
13769
AN:
152100
Hom.:
2163
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.317
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0292
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.0717
GnomAD2 exomes
AF:
0.0237
AC:
5949
AN:
250778
AF XY:
0.0170
show subpopulations
Gnomad AFR exome
AF:
0.326
Gnomad AMR exome
AF:
0.0135
Gnomad ASJ exome
AF:
0.00189
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000643
Gnomad OTH exome
AF:
0.0108
GnomAD4 exome
AF:
0.00914
AC:
13212
AN:
1444808
Hom.:
1848
Cov.:
26
AF XY:
0.00786
AC XY:
5657
AN XY:
719828
show subpopulations
African (AFR)
AF:
0.324
AC:
10654
AN:
32852
American (AMR)
AF:
0.0157
AC:
702
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00123
AC:
32
AN:
26008
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39542
South Asian (SAS)
AF:
0.00106
AC:
91
AN:
85890
European-Finnish (FIN)
AF:
0.0000189
AC:
1
AN:
53014
Middle Eastern (MID)
AF:
0.0150
AC:
86
AN:
5734
European-Non Finnish (NFE)
AF:
0.000413
AC:
453
AN:
1097226
Other (OTH)
AF:
0.0199
AC:
1193
AN:
59844
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
443
886
1328
1771
2214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0908
AC:
13819
AN:
152218
Hom.:
2173
Cov.:
32
AF XY:
0.0875
AC XY:
6512
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.318
AC:
13170
AN:
41458
American (AMR)
AF:
0.0290
AC:
444
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68034
Other (OTH)
AF:
0.0710
AC:
150
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
461
922
1382
1843
2304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0331
Hom.:
2104
Bravo
AF:
0.102
Asia WGS
AF:
0.0170
AC:
60
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000889

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala103Ala in exon 4 of CDC14A: This variant is not expected to have clinical s ignificance because it has been identified in 32.67% (3374/10328) of African chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs28361212). -

Oct 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.081
DANN
Benign
0.51
PhyloP100
-4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000022
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28361212; hg19: chr1-100856380; API